Omega Q2 net income $117M ($0.45 EPS); YTD investments $648M; AFFO guidance raised

OMEGA HEALTHCARE INVESTORS INC

2024-Q2 EPS reported $0.72 revenue$496,044,000

Net income of $117M ($0.45 per share) vs $62M ($0.25) in Q2 2023; Nareit FFO $189M ($0.72).
Adjusted FFO of $185M ($0.71 per share) vs $183M ($0.74) in Q2 2023.
Completed $221M in Q2 new investments ($115M acquisitions, $106M loans); $373M in Q3 to date.
Issued 8M common shares for $245M; repaid $400M senior unsecured notes.
Full year 2024 AFFO guidance raised; YTD new investments total $648M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.